Actual Coronavirus Testing Options Examined

By: Zach Segal, Published on Aug 13, 2020

Fever cameras have emerged as an indirect and flawed way to test for coronavirus. But what about actual coronavirus tests that directly test for the disease?

IPVM Image

Inside this note, IPVM examines the 5 main types of coronavirus testing options:

  • PCR/Molecular
  • Rapid PCR
  • Saliva Based Molecular
  • Antigen
  • Antibody

We explain how they work, how long it takes to get results, how much they cost, how widely available they are, and what the projections are for improvements in such testing.

Can actual coronavirus testing provide a better solution than fever cameras? We examine inside.

Update: As new testing methods are expanded and research continues we will continue to update this article.

Executive *******

*** ********* ***** ** entering **********, *** **** promising ****** ** ****** testing *** **** ** still ** ***********. *** most ****** **** (***/*********) is *** ********* *** too ****-********* ** ** applicable. ***** *** *** Antigen ***** ***** **** provide ****** ******** ******* in **-** ******* ***** be **** *** ********** testing *** ********* ** situations **** ***** *** waiting. ** ********, ******** tests ***** **** **** if ******* *** *** coronavirus *** ****** ******** it.

IPVM Image

Asymptomatic *** ************** ******

****** ***** *******, *********** tests *** ******** ** detect ***** **** *** virus **** ** **** are ************ ** **************. People ***** **** ********** ** the *** **** ****** symptoms.*** ****** ********* **** ******* 80%** ****** **** **** cases ** *** ************. So, **** ********** ****** may *** **** ********. This ***** *********** ***** can ***** **** ********** individuals **** ***** ******* will ****.

Common *********/*** ****/***** ****/******* **** *************

IPVM Image

*** **** ****** **** type ** *********/*** ***** which ********* ********, *********, ****, uncomfortable, *** ****** **** supply *********. **** *** ********* the **** ******** ****** for ********** *********** *** are *** ****** *** screening ** ******** *******. They *** ******* **** Amplification ** ******* *** amount ** *********** ** a ******, ****** **** more ********. ***, ************* causes *** ***** ** be *********, ********-*********, *** time-consuming. * *** ***** process * **** ** an ****, *** ******* need ** ** ***** to *** *** *** backlogs *****, ******* ******* to ***** **** **** after *******. **** *** also ************* ******* * nasal **** ***** ** be ******** **** **** the ****. ****,****-************ ******** *** ** ******** as ************** ************, ******* people ** *** *** the **** *** ****** up ***** *****. **** means ******** ******* ******** medical ************* *** ****** be *******-****. ** ** unclear *** **** ***** tests **** ** ************** carriers, *** **** *** currently *** **** ******** option.

*** *******,*** *** ** ***** daily *** ********* *** '******'.

Debate **** **** ** * ******** ******:

***** ** * ****** over **** ****** ***** as * ******** ***/******* Acid ************* *****. ***** tests ***’* **** * result ** ******** ** positive, *** *******, **** the ****** ** ************* cycles (**) ******** *** the ***** ** ** detected. ***** ******* **** more *****, *** * decrease ** ** ** 1 *********** ** * roughly ******** ** *** viral ****. **, * CT ** ** ***** someone *** ******* ***** the *********** **** ** a ** ** **. This **** ******* ***** that *** ******* **** amplification. **** ***** ***** any ***** ***** ** as * ******** ******, but**** ***** **** ** too****.* ****-******** ***** ********* **’* ***** ** was *** *** *** the ***** ** ********* in * ***, ********* that ***** ****** **** not **********. ***, ****** **** ***** ******** that******* ******* *********** ***** cutoffs ** **-** ** below **. **** ** significant, ******* * ******** of ******** ******* *** be **** *********** *** are ** ****** **********, who **** **’* ***** 30 ** **. ** means **** ********* *** being ****** ** ******* tracing *** ********* *** people *** *** ** longer **********.

Rapid *** *****

IPVM Image

***** ***** *** ***** are ******* ** *********** PCR ***** *** ********* on * ******* *****, so ******* *** ******* and ***** ** **** for *********.

***** ***** ***** *** less ******** **** *********** PCR ******** * ******** ****** does *** *********** **** out ***********.** ******* (**-** *******), ***********, and *** ** **** with ******** *********. ***** are ***** * *** of ******** ***** ***** PCR ***** ******* **** are * ****** *********** and **** *** **** widely ****.

Saliva ***** ********* *****

IPVM Image

****** ***** ********* ***** are ***** ******** ** an ***********, ****, ****** accurate ******** **** *** be **** *** *********.

**** ******* ****** ******* will ** **** ************ ***** ***** *****, but*** ***** *** ***** saliva **** ********. **** *** **** (1-15 *******) *** ***** cost **** **** $* making **** **** **********. They *** **** ******* on ******** *********, ***** could ******* ****** *********. Also, ****** ***** *** comfortable *** ******* *** easy *** ****** ** take **********. **** ***** that ** ******* ******* is ********, *** ****** professionals *** *** ****** for **********. ** **** means **** ****** *** dislike ***** ***** *** avoid ***** **** ******* them ***** *** ****** with ******-***** ********* *****.

***** **********,************ *** ********* ********* *** ************* by *** ***. ******** ********** ** *** testing** ***** ******, *********** ($1-$5), *** ****. ****, the ****'* ********** ***** ******** **** the ***. ******* *** ****** the ****, *** ********* the ******* **** *** PCR ***** **** ******* undertake, ** ***** ** verify *** ****'* ******** on ************ ********. ****** **** *********** $***,*** to *** ***** ******** and *** ****** ***** the ***.

Antigen *****

IPVM Image

******* ***** *** **** accurate **** *********** *** molecular ***** *** **** established *** ***********, *** they *** ****** *** cheaper. **** **** *** proteins ********** **** *********** and ** *** ******* amplification. ***** *** ********* on * **** *****, much **** * ********* test, *********** *** **** for ********* ********* ** medical *************. ***** ******** results *** ********** ********, the*** ***** **** ******** results** *** *********** **** out ***********. ***, **** are ***** *** ***** be **** ********** **** molecular *****, **** **** tests *** ******** *** use *** ****** ****** are *********.***** ** ********* ******* tests **** ********* *** FDA **************** **** *** ******** developed, ** ********** ** still ***** ****** ** and ******** ** *******.

******:*** *.*. ********** *** purchased *** ************ ******* ***** ** increase *** *********** ******* capabilities ** *** ****** States. *** ************, ***** Labs, **** *** ***** take ** ******* ** run *** *** * shallow **** **** **** can ** ****-************. *** manufacturer ****** **% ********* with *** *****, *** it ** ******* ** that ** ***** ** self ** ************** ************ nose *****. ***** ***** are **** ******** ** individuals **** ******** *** Dr. ******* ********, ** infectious ******* ********* ** the ******* ********** ** South ********, **** *** NY ***** **** ** is ****** ** *** tests **** **** **** tested ** ************ ********:

** ***’* **** ******** about ***** *****’ ******** in ************ ********, ... We **** ** ** using ***** **** **** been ********* ** ***** performance.

*******, ******* **** ** not **** ** *************,**** *** **** **********-*********.

Benefits ** **** ******** ***** *******

*********** ***** ***** *** find ***** *********** *** testing ***** **** ******* traditional *** ***** *** too ****, ******-***********, *** cost-prohibitive *** ******** *******. They *** **** ** used *** *********, ***** could **** **** ********* facilities. ************** *** ************ individuals **** ** **** likely ** **** ***** tests, *** ***** *********** are *** **** ********* people ** ****. **** if **** *** **** accurate **** *********** *** tests, ***** ***** *** more ******** **** ** testing. *******, **** ** a **** ****** * case, * ******-** **** could ***** **. *********** PCR ***** *** *** inaccessible *** ******** *******, but **** ** ***** rapid ***** ***** ** taken ********** ** ****** populations. ****** *** ***** molecular, ******, ** ******* tests *** *** ***** may ** **** ******** than * ****** *********** molecular ****, *******, **** accessible, *** ***** **** a ********** ****** ** time. ****, *** ********** in ******** *** ** overstated ******* ** *** high ** ********* *** tests **** ******* **** Amplification ***. ******** *** results **** **-****** ********** individuals *** ** *********** counted ** ***** ********* for ***** *******, ******* of ***** ********* *** PCR *****.

Antibody *****

IPVM Image

********/***** ***** ****** ***** someone *** *********** ** the ****,*** **** *** *** used ** ******** ****** cases. ******** ***** *** fast *** ********** ******** but **** ** *** work **** ***** *-* weeks ***** *********** ***********. In ********, ***** ** no *** ** *************** between ******* *** *** an ****** ********* *** someone *** *** ** active ********* ** *** past. **** ***** ******** tests *** *** *********** useful ** ***********. ******** tests *** * **** way *** ****** ****** officials ** ******** *** percent ** * ********** that *** *********** ** the ****, ******** ********* to ****** ****** ******* models.

** ** ********* ** remember **** * ******** result *** ******** ** active *********, ** ****** should *** ***** * positive ****** ** ********. Do *** *** **** you ****** ****** ***********, just ******* *** **** a ******** ******** ****.

How *** * *** ******?

**** ******* ** ***** you ****, *** **** likely ******* **** ********** provider *** *** ****** be **** ** ******* options ******* **** ***** healthcare ******. ***** *** largely ***** *********** ********** in ******* ******* ** through ******* ******* ***** they ***** ******* *************. In ********,* ************ ******* **-**** ***** that *** **** **** for * ****** ** the *.*. **** **** between $***-$*** ********* ** ***** ******* by ************** *** ***** ***. Currently, **** *********** *** and ******** ***** *** widely ********* ******, *** traditional *** ***** *** less ******** **** *** swab ** ****-************. *******, there ** * *** of ***** *********** ***********, and**** ***** *** ***** sold** ** ** ********* to ****** **** **** is ********** ** *********** authorities.

Corporate *********

** ** ******** *** large ************ ** ****** relationships **** **** (** their *** ***) *** at ***** *** ******* is ********* ***** ** smaller ************.***** ******** *** ************* *** **** ****** and ***** ****, ** ensure ***** ********* *** get ******, ********* ** ******** *** own***, *** *** ******* companies, ***** *** ***** options. ** *** **,********* ********* ******* *********** solutions ********* *** *** antibody *****. *******'* ******** will ****** **** **** than ********** ***** ******* of ****, *** **** still ** ********** *********, take ******* **** ** process, *** ** **** at ****, ******** *** suffer *** ** ******** sample **********.

Future ** *******, ***** ***** *********, *** ********* ****** *****

******* ********* *** ******** new ******* *** ********* tests **** ***** ****** the ********* *********.**** ***** ******* *** rapid ************** *** ***** ****** and ***** **** ** widely *********. ** ********, at ******** *****-**** ********* * ******-***** kiosk. **** ***** ******** results ***** ** ******* but *** ******* ** decrease ********** ****. *********** would **** * ****** sample, **** * ***** amount ** ****, *** receive * ****** ******** diagnosis. **** ***** ** valuable *** ********* ******* areas ** **********. ******** the ***** **** ****** be **** ******** **** traditional *** *****, ** will ** **** **** accurate **** ***** ********* for *********** *********. **** being ****, *** ******* landscape ** ***** *** deception *** ** ** important** *** ******* ***** the ****** ** ******* startups.

More ***********

**** ** ******** ** a ******* ************. *** more ********* / ******* data, **** ** ********** for ********** *** *********** (****) * *** ************* non-profit **** ** ******** Coronavirus ***** *** ********* their ********. ****, *** accuracy ** ********* **** real-life ********, ***** ******** complicated **********.**** *** ******* ******* of ******** *************** ******** ** ******* and *** * ***** that *** **** *** interpret **** * ******** test ****** ***** ***** on *** ****'* ******** and **** ********** ** being ********.

Outlook / ******

*** ********* ** ******* reports ** **** ******** in ***** *** *** saliva *** ******** ***** in ****. *** *** or ****** **** ******* is, ** ******, ******* now. *******, ** **** to ******** ** ***** these ************ ** ******* better *********** ** ********** look ** ******* ********, from ***** ******* ** spit *****, ** ****** secure ***** *************.

Comments (24)

* ********** *** ***** lists ********** ***** ****. Meanwhile *** ******* ***** with *** ********* **** fever ******* *** ** indirect *** ****** *** to **** *** ***********.

** ***** ***** ** useful ** ******* ***** cameras *** ***-******* *********** in * ********************* ******* **** ********* the ***********. ** ***** be ** *** ****** for **** ******** ******.

****** *** *** ****. We've ******* *** *****.

********

***** ***.

********* ** *** ************ user *********** ** ******* reason **** ***** **** a ***** ********.

*********? ****...

IPVM Image

******* **** ********* ******* can ** ***** ** a ****** ******** ** corona ***** ******* **** may ** ********* ** a ***** *** ******? Hint: ****** ** **** a *** ****.

**** - *** ***** Blocked **********

IPVM Image

IPVM Image

***** ****, ****! ***** a *** ********* (********* Russia, ************, *** *******) *** currently ********* ********* ** present ******** *** ***** to **** *********. (**** is * ***** *** article ** *** ***** as ** ******* ** U.S. ********, ** *** updated ** ***** **** in **** *** *** not **** ******* ** over *** *****.)

***** ************* ************ *** still **** ** ** tourists | *** ******

*** **** *** **** you **** ********* ** a ********* ** *****-** travelers, **** ****** ********* requesting **** ******* *** older **** ** ** in **** ***** ** hours **** *******.

"*** ****** ********* **** ******* 80%** ****** **** **** cases ** *** ************."

** **** ** ****, and * **** ***** I **** **** ***** studies **** *** *******, then **** ***** '***** cameras' *** ** *** greatest **** ** *** century.

****** **** **% ** infected ****** ** *** have * ************ ****** temperature ** ******* * 'fever ******'. **** ****** at **** **% *** could ** ********.

*** ********* ************** ** many (****?) '***** *******' means ***** ********** ** further *******, ** * guess ** **% ** more. **** ****** ** best * **% ***** rate. **** ** ******* reduced ******* **** ****** have * ********* ***** body *********** & **** they **** * ***** their **** **** **** up ** **** ** considered ** ** *** normal *****.

** ** ******** ***** we ****** ***** ********* that **** ***** **% of *** ****? ***** we ****** * ****** install **** **** ******* 10% ** *** ****?

** * ********* ****** scenario, ***** ** ****** a ****** ******* **** only ******* **% ** people ******* ** * hole?

**** *** * **** had **** ************ ******* times. ******** *** ********* stated *****, ** ***** are *** ****** ** a ***** ** *,*** who **** *********** *** you **** *** ****** of ******** ** ** them ** **** ** them ** ***, ***** option ***** *** ******?

*************, ***** *** ****** of *** *****, **** people *** **** **** happy ** ****** ********* of ******* **** * solution **** ** '*****' cameras **** *** *** sake ** ******** ******** those ** ******** ***********.

******** * ***** **** you ******, ** ** better ** ***** ***** 10. ******* *** ********* BS **** '***** *******' implies * ***** ******* success **** **** *** possibly ** ******** ** the **** *****.

**** * **** ****** every ****** ********* ** selling ***** ******* ** lying ** *** *** users, ****** ** ******** to **** *** **** story, ** ** ****** outright ********** ******.

* ********** ***** **** you. ** * ***** private ******* ****** ** buy *** '*****' ******* and *** **** ** the ******* ** *****, then **** ***** *** be *** **********.

** *** **** ****, it ** ********* ** see ********* *******, ** least ****** *** ********, from ****.*. ******* *******, ** ************ *********, ****** ************* ***** ******* ** the ****** ** ********* solutions, *** ******* **-***** ** ************* for ********* ********.

*** ****** ** ***** sold *** **** **** these ******* **** ***** anyone *** ******** ******* with **** * ****** fever, ***** ** ******* the **** *** ******** closer ** *** */** that *** ******* *****, if ****.

.

*'* ***** ** **** to *** **** ******** brings ** *** *****.

** *** ******* **** - **** ** * really ***** ******* ****. The ******* *** ***** make **** ***** **** highly ********** (*** ***** positives *** *********). ** is **** ** **** some ****** ** ******* to ***** ***** *** accurate *** ***** *** hygiene *******.

* ***** *** *** is ***** *******, *****, and **** ** *****. I **** *** ******* who *** **** **** exposed, **** *** ** wait *** *** ******** carrier ** *** ******* before **** *** ******, so ******* **** ** lost ****.

** **** * ******** locally ******* ** *** saliva **** *** **** past *** ******. **** used ***** *** ********* on * ****** ***** for ******* *** "****". From **** * **** it ***** *********. *** one ***** * ***** from ******* *** *** done *** ****** **** is ***** **** ** actually ******* ****** ****** for *** ****. *** have ** *** *** or ***** ******** *** 30 ******* ****** *** give *** ******.

* *** *** ***********, "Let's ***** **** ***** Test", **** **** ** I *** ******* ******** for * *** ** days *** *** ******** a ******* *** **** prior. * **** * mask *** ***** **** except ** *** ** drink. *** ***** *** was *** *** ***** for *** ****** ** people. * **** **** a *** ********* ****** any *** *** ** it **** ***** ** go ***** **** *** test. *********** *** **** came **** ********.

**** **** ** **** all ***** ***** **** get ****** *** ****** as **** ******* ** done *** **** ******* are ********* *** *********.

*** *** **** ******* tests *** ************ ** the *** *****. ** *** *** reach *** ** *** NBA ** *** *** they **** **** ******* testing ******* ** ******-***** molecular *******, *** ** is *********** ** ****.

*** ****** ********* *** process:

**** ******** ******* ** a ******** **** ** the ***** ******** ** hand **** ******* ******* and ******* ************. **** we ********* **** * testing **** *** *** coronavirus ***** ****. ** results **** **** -- negative -- ** ** minutes. **** *** ********** an ******* **** -- slightly **** ******** **** the **** ****** *** molecular ****, ***** ** a *** ***** ******** results, *** ********* **** faster. ** *** **** masks *** *** ********* of *** **** ** the ******* ****.

******* ******,****** ********* * ****(** *******) - $* antigen ****, **** *****'* require *** *********. **** are ********* ******* ** production ** ******* ** million ***** * ***** and **** ********* *** Authorization **** *** ***.

** ** ***** **** based, ** *** ******** testing * ******* ************ will **** ** **** the ****. **** ***** be **** ** ********, drs *******, ***. *** could **** **** * nurse ** **** ** door ******* * ********** dorm ** ***** ********* complex ** ****.*** **** and **** ** *** equiptment ** **** *******.

*'** ******* *** ******* to ******* *********** ** the ****** **** **** should ***** ** * positive *** ******. **** argue **** *** ********* is *** ***, *** no-longer ********** *********** *** getting ******** **** *******.

* **** ******* *** article ********** *.*. ********** *** purchased *** ************ ******* ***** ** increase *** *********** ******* capabilities ** *** ****** States. ********* ** *****, the ************, **** **** 15 *******, ***** **** PCRT ***** **% ** the ****, *** ******* a ******* **** ****. These ***** *** **** approved ** ****** **** symptoms.

Read this IPVM report for free.

This article is part of IPVM's 6,538 reports, 881 tests and is only available to members. To get a one-time preview of our work, enter your work email to access the full article.

Already a member? Login here | Join now

Related Reports

Dogs For Coronavirus Screening Examined on Aug 06, 2020
While thermal temperature screening is the surveillance industry's most...
Directory of 206 "Fever" Camera Suppliers on Aug 04, 2020
This directory provides a list of "Fever" scanning thermal camera providers...
US Startup Fever Inspect Examined on Aug 03, 2020
Undoubtedly late to fever cameras, this US company, Fever Inspect, led by a...
Dangerous Hikvision Fever Camera Showcased by Chilean City on Aug 07, 2020
Deploying a fever camera outdoors, in the rain, with no black body, is...
Colombia's President Promotes Bad Hikvision Fever Camera Setup on Jun 17, 2020
Colombia's President Iván Duque has promoted a haphazard Hikvision fever...
Dangerous Hikvision Fever Screening Marketing In Africa on Sep 15, 2020
A multi-national African Hikvision distributor is marketing dangerously...
Temperature Screening Is Ineffective, Says US, UK, Canada, Israel, And Ireland Health Leaders on Aug 25, 2020
Health leaders around the world are increasingly speaking out about the...
FLIR Screen-EST Screening Software Tested on Jun 30, 2020
In our FLIR A Series Test, the cameras' biggest drawback was their lack of...
Omnisense "Mass Fever Screening and Pandemic Control System" Examined on Jun 11, 2020
Omnisense Systems is marketing a "Mass Fever Screening and Pandemic Control"...
FLIR A Series Temperature Screening Cameras Tested on Jun 04, 2020
FLIR is one of the biggest names in thermal and one of the most conservative....
Worst Over But Integrators Still Dealing With Coronavirus Problems (June Statistics) on Jun 30, 2020
While numbers of integrators very impacted by Coronavirus continue to drop,...
Detecting Coronavirus Fevers With Thermal Cameras on Mar 15, 2020
MAY 2020 Update: This post was our early examination of these systems being...
Hanwha Face Mask Detection Tested on Jul 01, 2020
Face mask detection or, more specifically lack-of-face-mask detection, is an...
Anixter Runs Fake Coronavirus Marketing Using Shutterstock Watermarked Images on Jul 24, 2020
Coronavirus faked marketing is regrettably commonplace right now but Anixter...
ZKTeco Body Temperature and Mask Detection Reader Tested on May 26, 2020
While dedicated fever cameras emerged first, now tablet/kiosk fever detectors...

Recent Reports

Hanwha AI Object Detection Tested on Sep 28, 2020
Hanwha has added detection and classification of people, cars, clothing...
Favorite Access Control Manufacturers 2020 on Sep 28, 2020
200+ Integrators told IPVM "What is your favorite access control management...
New Products Show Fall 2020 Starts Tomorrow! on Sep 27, 2020
Tomorrow, IPVM's sixth online show will feature New Products from over 25...
OnTech Smart Services Partners With Google and Amazon To Compete With Integrators on Sep 25, 2020
A pain point for many homeowners to use consumer security and surveillance is...
The Future of Metalens For Video Surveillance Cameras - MIT / UMass / Immervision on Sep 25, 2020
Panoramic cameras using 'fisheye' lens have become commonplace in video...
Hikvision Sues Over Brazilian Airport Loss on Sep 24, 2020
Hikvision was excluded from a Brazilian airport project because it is owned...
China General Chamber of Commerce Calls Out US Politics on Sep 24, 2020
While US-China relations are at an all-time low, optimism about relations...
Verkada Disruptive Embedded Live Help on Sep 24, 2020
Call up your integrator? Have someone come by the next day? Verkada is...
IP Networking Course Fall 2020 - Last Chance - Register Now on Sep 23, 2020
Today is the last chance to register for the only IP networking course...
Drain Wire For Access Control Reader Tutorial on Sep 23, 2020
An easy-to-miss cabling specification plays a key role in access control, yet...
Norway Council of Ethics Finds Hikvision Human Rights Abuses "Ongoing" on Sep 23, 2020
Hikvision's involvement in "serious human rights abuse" in Xinjiang is...
IPVM Camera Calculator User Manual / Guide on Sep 23, 2020
Learn how to use the IPVM Camera Calculator (updated for Version 3.1). The...
Installation Course Fall 2020 - Save $50 - Last Chance on Sep 22, 2020
This is a unique installation course in a market where little practical...
SimpliSafe Business Security Launched Examined on Sep 22, 2020
SimpliSafe has launched "SimpliSafe Business Security" that the company...
FLIR CEO: Many New Fever Entrants "Making Claims That The Science Just Won't Support" on Sep 22, 2020
FLIR's CEO joins a growing number calling out risks with fever / screening...